Dorottya Angyal

ORCID: 0009-0003-0900-1966
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Inflammatory Bowel Disease
  • Microscopic Colitis
  • Eosinophilic Esophagitis
  • Bryophyte Studies and Records
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Celiac Disease Research and Management
  • Botany and Plant Ecology Studies
  • Anorectal Disease Treatments and Outcomes
  • Spider Taxonomy and Behavior Studies
  • Eosinophilic Disorders and Syndromes
  • Autoimmune and Inflammatory Disorders
  • Diagnosis and treatment of tuberculosis
  • Pregnancy and Medication Impact
  • Diverticular Disease and Complications

Semmelweis University
2022-2025

University of Sopron
2010

Background: Inflammatory bowel diseases (IBDs) are chronic conditions that negatively affect the patient's quality of life. With spread biopsychosocial model, role mental health in activity and course inflammatory disease is becoming more recognized. Our study aimed to assess prevalence anxiety depression IBD patients our tertiary referral center determine predictive factors these conditions. Methods: A total 117 were included consecutively between 1 December 2021 28 February 2022. We used a...

10.3390/jcm13072002 article EN Journal of Clinical Medicine 2024-03-29

Limited data are available on long-term disease outcomes in elderly-onset (EO) inflammatory bowel diseases (IBD) from well-defined population-based cohorts. Our aim was to analyze incidence, course, surgery rates and therapeutic strategies of EO IBD a prospective cohort.

10.1093/ecco-jcc/jjaf003 article EN PubMed 2025-01-06

Bevezetés: A vérszegénység a gyulladásos bélbetegségek egyik leggyakoribb szövődménye és betegség súlyosságának mutatója. Célkitűzés: Vizsgálatunk célja az anaemia gyakoriságának, etiológiájának, prediktív tényezőinek kezelésének felmérése volt bélbetegségben szenvedő betegeket kezelő két tercier centrum betegpopulációjában. Módszer: Retrospektív, keresztmetszeti vizsgálatunkban egyéves időszakban (2022. 06. 01. – 2023. 05. 31.) Semmelweis Egyetem klinikáján megjelent betegek körében mértük...

10.1556/650.2025.33197 article HU cc-by Orvosi Hetilap 2025-01-12

Long-term data on ustekinumab in real-life Crohn's disease patients are still missing, though randomized controlled trials demonstrated it as a favorable therapeutic option. We aimed to evaluate ustekinumab's clinical efficacy, drug sustainability, and safety prospective, nationwide, multicenter patient cohort with three-year follow-up. treatment were consecutively enrolled from 9 Hungarian Inflammatory Bowel Disease centers between January 2019 May 2020. Patient characteristics, history,...

10.1038/s41598-024-65987-1 article EN cc-by Scientific Reports 2024-06-28

Summary Background Few population‐based studies have investigated the prevalence and disease course of perianal manifestation in Crohn's disease. Aims To analyse outcomes including medical therapies need for surgery, over different therapeutic eras based on time diagnosis; cohort A (1977–1995), B (1996–2008), C (2009–2018) Methods Patient inclusion lasted between 1977 2018. We followed patients prospectively, regularly reviewed both in‐hospital outpatient records. defined a surgical...

10.1111/apt.17836 article EN cc-by-nc-nd Alimentary Pharmacology & Therapeutics 2023-12-19

153 spider species were collected in the reedbed of Lake Velence. This is first faunistical survey about area.

10.24394/natsom.2010.17.133 article EN Natura Somogyiensis 2010-01-01

Abstract Background: Long-term data on ustekinumab in real-life Crohn’s disease patients are still missing, though randomized controlled trials demonstrated it as a favorable therapeutic option. Aims: We aimed to evaluate ustekinumab's clinical efficacy, drug sustainability, and safety prospective, nationwide, multicenter patient cohort with three-year follow-up. Methods: treatment were consecutively enrolled from 9 Hungarian Inflammatory Bowel Disease centers between January 2019 May 2020....

10.21203/rs.3.rs-3952188/v1 preprint EN cc-by Research Square (Research Square) 2024-03-13

A hypereosinophil szindróma tartós eosinophil-túltermeléssel járó, a következményes eosinophilinfiltráció és mediátorfelszabadulás miatt többszervi károsodást okozó kórkép. Etiológia szerint megkülönböztetünk myeloproliferativ eredetű, parazitafertőzéshez, solid tumorhoz T-sejtes lymphomához társuló, valamint idiopathiás formát. Esetismertetésünkben 49 éves férfit fogyás, alszári oedema, tachycardia vettük fel osztályunkra. Laborjából jelentősen emelkedett epeúti obstrukciós paraméterek,...

10.1556/650.2022.32606 article HU cc-by Orvosi Hetilap 2022-10-30
Coming Soon ...